Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05538338 · ClinicalTrials.gov registry record · NA
Platelet Rich Plasma for Insufficient Endometrium
A NA study of Infertility of Uterine Origin, sponsored by Reproductive Medicine Associates of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT05538338 is a NA study of Infertility of Uterine Origin that is actively recruiting participants, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05538338, a NA study of Infertility of Uterine Origin, is actively recruiting participants, sponsored by Reproductive Medicine Associates of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effectiveness of an intrauterine PRP infusion on endometrial thickness and in vitro fertilization (IVF) outcomes in a population of infertile women with a history of unresponsive thin endometrium.
Conditions Studied
Interventions
- OTHER Platelet Rich Plasma Intrauterine infusion
- OTHER Normal saline Intrauterine infusion
Study Locations (1)
New Jersey
- Reproductive Medicine Associates of New Jersey - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-10-15 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05538338
The ClinicalTrials.gov registry entry for NCT05538338 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility of Uterine Origin appearing as the primary indexed condition, and to 2 interventions - of which Platelet Rich Plasma Intrauterine infusion is the first listed.
NCT05538338 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05538338 about?
NCT05538338 is a clinical study titled "Platelet Rich Plasma for Insufficient Endometrium". To determine the effectiveness of an intrauterine PRP infusion on endometrial thickness and in vitro fertilization (IVF) outcomes in a population of infertile women with a history of unresponsive thin endometrium.
What is the current status of trial NCT05538338?
This trial is currently recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2022-10-15. Estimated completion is 2025-12.
What conditions does trial NCT05538338 study?
This clinical trial studies the following conditions: Infertility of Uterine Origin.
What interventions are being tested in trial NCT05538338?
The interventions under investigation include: Platelet Rich Plasma Intrauterine infusion (OTHER), Normal saline Intrauterine infusion (OTHER).
Who is sponsoring clinical trial NCT05538338?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05538338 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility of Uterine Origin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.